Braga P C, Rampoldi C, Ornaghi A, Caminiti G, Beghi G, Allegra L
Department of Pharmacology, Chemotherapy and Toxicology, School of Medicine, University of Milan, Italy.
Pharmacol Res. 1990 Sep-Oct;22(5):611-7. doi: 10.1016/s1043-6618(05)80053-2.
Proteolytic enzymes can act on the polymeric structure of the bronchial mucus, shortening the long chain of mucoproteins, DNA and other macromolecules, and thus reducing the viscosity of the mucus facilitating its expectoration. Seaprose (Flaminase, Puropharma) belongs to this class and is a proteinase from Aspergillus melleus and it is mainly used in traumatology, orthopaedics, gynaecology and pneumology. In the present study the in vitro activity of increasing concentrations (0.25, 0.5, 1%) of seaprose incubated with bronchial mucus samples (1 ml) was investigated by a rheological technique (transient test) that assesses changes in viscosity and elasticity. A dose-effect relationship between increasing concentrations of seaprose and the corresponding reductions in bronchial mucus viscosity was found. There was also a parallel reduction in elasticity after incubation with 0.5%, but an unfortunate distribution of values for 0.25 and 1% concentrations does not allow us to state whether there is a dose-effect relationship for elasticity.
蛋白水解酶可作用于支气管黏液的聚合结构,缩短黏蛋白、DNA及其他大分子的长链,从而降低黏液的黏度,便于咳痰。海普洛酶(弗拉米酶,普洛法玛公司生产)属于此类,它是一种来自黄曲霉的蛋白酶,主要用于创伤学、矫形外科学、妇科和肺病学领域。在本研究中,采用一种评估黏度和弹性变化的流变学技术(瞬态试验),研究了浓度递增(0.25%、0.5%、1%)的海普洛酶与支气管黏液样本(1毫升)孵育后的体外活性。研究发现,海普洛酶浓度增加与支气管黏液黏度相应降低之间存在剂量效应关系。用0.5%的海普洛酶孵育后,弹性也有相应降低,但0.25%和1%浓度下的值分布不理想,无法确定弹性是否存在剂量效应关系。